• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine

firstwordpharmaJuly 06, 2021

Tag: NPPA , Ibuprofen , ranitidine , carbamazepine

India’s pharmaceutical pricing regulator has allowed a one-time price hike of 50% for ibuprofen, ranitidine and carbamazepine, Business Standard reported.

NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine

After the latest increase, the price of carbamazepine, a drug used to treat epilepsy, would range from Rs 1 to Rs 4.61 per tablet. The new price of ranitidine, an antacid, would be in the range of Rs 1 to Rs 2.43 per tablet or per ml of liquid, while the price of ibuprofen, an analgesic, would be 59 paise to Rs 1.04 per tablet.

The National Pharmaceutical Pricing Authority (NPPA) allowed the price hike during its meeting held on June 28.


Previous:Oncodesign Appoints Aline Aubertin as an Independent Director of the Board of Directors

Next:France's Sanofi expects Covid vaccine to be ready by December

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

Ibuprofen

Ibuprofen
Ibuprofen Impurity 52

Ibuprofen Impurity 52
Ibuprofen EP Impurity I

Ibuprofen EP Impurity I
Carbamazepine

Carbamazepine
Ibuprofen

Ibuprofen
Carbamazepine（298-46-4）5-carbamoyl-5h-dibenz[b,f]azepine

Carbamazepine（298-46-4）5-carbamoyl-5h-dibenz[b,f]azepine
99% up GMP DMF Ranitidine hydrochloride 66357-35-5

99% up GMP DMF Ranitidine hydrochloride 66357-35-5
Ranitidine Hydrochloride Injection

Ranitidine Hydrochloride Injection
Ranitidine Hydrochloride

Ranitidine Hydrochloride
Ibuprofen Suspension

Ibuprofen Suspension

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service